TASTE MASKING OF DIRECTLY COMPRESSED PHENYTOIN SODIUM ORALLY DISINTEGRATING TABLETS BY SOLID DISPERSION TECHNIQUE

Main Article Content

Pienkit Dangprasirt
Warumporn Wongthongdee
Supatchalida Nimsumlee
Annus Yusop
Moleephan Dangprasirt

Abstract

Phenytoin sodium (PS) orally disintegrating tablets were prepared by direct compression using various contents of spray-dried lactose and microcrystalline cellulose (Avicel® PH 102) as direct compressible diluents. Crospovidone (Polyplasdone® XL), magnesium stearate and talcum were used as disintegrant, lubricant and glidant, respectively. Mannitol or sorbitol and saccharin sodium were also utilized as sweetening agents to mask the bitter taste of PS. The orally disintegrating tablet formulation that provided the fastest disintegration time and provided the satisfied drug dissolution was selected as the optimum formulation. A solid dispersion technique, coprecipitation method, was applied as an attempt to mask the bitter taste of PS from the optimum orally disintegrating tablet formulation using mannitol or sorbitol as carrier. The orally disintegrating tablets prepared by PS-sorbitol and PS-mannitol solid dispersions provided better taste than those prepared by PS-sorbitol and PS-mannitol physical mixtures. However, the dissolution of orally disintegrating tablet prepared by PS-sorbitol solid dispersion was slower than that of the orally disintegrating tablet prepared by PS-sorbitol physical mixture and did not meet the USP requirement of not less than 85% drug dissolved at the 30th minute time interval. The orally disintegrating tablets prepared by PS-mannitol solid dispersion and physical mixture exhibited comparable satisfied disintegration times of 0.13 and 0.20 minutes, respectively. Their dissolution profiles were also similar and met the USP requirement. Inclusion of menthol in the orally disintegrating tablet consisted of PS-mannitol solid dispersion improved the tablet taste due to the additional cooling sensation. The drug dissolution from this orally disintegrating tablet formulation met the USP requirement. However, the reduction in tablet dissolution rate was observed in the initial period of drug dissolution.

Article Details

How to Cite
1.
Dangprasirt P, Wongthongdee W, Nimsumlee S, Yusop A, Dangprasirt M. TASTE MASKING OF DIRECTLY COMPRESSED PHENYTOIN SODIUM ORALLY DISINTEGRATING TABLETS BY SOLID DISPERSION TECHNIQUE. Interprof J Health Sci [Internet]. 2023 Oct. 5 [cited 2024 Dec. 6];16(2):117-24. Available from: https://li05.tci-thaijo.org/index.php/IJHS/article/view/194
Section
Research Articles

References

Anusha P, Nirajana VA, Mohammed S, Jilani S, Krishna M, Harish G. 2013. Development and evaluation of drotoverine taste masked tablets with improved dissolution efficiency using solid dispersion technique. IJRPB. 1(3): 275-80.

Bandelin FJ. 1989. Compressed tablets by wet granulation. In: Lieberman HA, Lachman L, Schwartz JB, editors. Pharmaceutical dosage forms: tablets. 2nd ed. New York: Marcel Dekker; pp 158.

Carlin Brain AC 2008. Direct compression and the role of filler-binderssss. In: Ausburger LL, Hoag SW, editors. Pharmaceutical dosage forms: tablets. 3rd ed. New York: Informa Healthcare; pp 189.

Dangprasirt P. 2015. Formulation of propranolol hydrochloride orally disintegrating tablets by direct compression using simplex lattice design. Bull. Health Sci. Technol. 13(2): 39-46.

Halm HA. 2008. Orally disintegrating tablets and related tablet formulations. In: Ausburger LL, Hoag SW, editors. Pharmaceutical dosage forms: tablets. 3rd ed. New York: Informa Healthcare; pp 293.

Hirani JJ, Rathod DA, Vadalla KR. 2009. Orally disintegrating tables: A review. Trop. J. Pharm. Res. 8(2): 161-72.

Rowe RC, Sheskey PJ, Quinn ME. 2009. Handbook of pharmaceutical excipients. 6th ed. Chicago: Pharmaceutical Press.

The Department of Health, Great Britain. The Department of Health, Social, Services and Public Safety, Northern Ireland. 2015. British Pharmacopoeia. Volume V. London: The Stationary Office. Appendix XII C V-371.

The United States Pharmacopeia. The National Formulary. 2014. USP 37 and NF 32. Volume 1.1. Volume 1.3 Volume 3.2. Rockville: The United States Pharmacopeial Convention.

U.S. Department of Health and Human Services. Food and Drug Administration. 2008. Guidance for Industry: Orally Disintegrating Tablets. Rockville: Center for Drug Evaluation and Research.

WHO Technical Report Series, No 937, 2006, (Accessed on Nov. 25, 2017, at http://academy.gmp-compliance.org/guidemgr/files/WHO_TRS_937_ANNEX8.PDF)